Health for a Prosperous Nation
Dar es Salaam, Tanzania
NCT Number: NCT07687888
Implementation study comparing standard pre-exposure prophylaxis (PrEP) services to four models of pharmacy-based PrEP access for young women aged 18-24 (YW) in Tanzania. At 9 months, all sites converge to one pharmacy-based PrEP model and are randomly allocated to one of two cost sharing models to increase the program's potential for sustainability.
Trial opening soon.
Get Notified18 year–24 year
Female
Interventional
Not applicable
Dar es Salaam, Tanzania
This study will evaluate the effectiveness of pharmacy-based PrEP implementation for YW in the Lake Zone, Tanzania. Four models for pharmacy-based PrEP delivery will be evaluated and compared to pharmacies that do not provide any PrEP services for 9 months (phase I of the implementation study). The PrEP implementation models build on one another with each pharmacy-based PrEP model providing progressively expanded access to PrEP in pharmacies for YW.
All PrEP implementation models will be implemented alongside a girl-friendly loyalty program (Mwotaji Program) offering free sexual and reproductive health products including HIV self-test kits, pregnancy tests, and contraceptives.
Comparison: Standard facility based PrEP services to YW.
After 9 months (phase II), all pharmacies will implement the best performing PrEP model, based on findings from phase I. Moreover, all 50 pharmacies will implement cost-sharing. The investigators will assess acceptability, feasibility, and potential for sustainability of the pharmacy-based PrEP models. Two cost-sharing approaches will be randomized across the CRPS in a 3:2 ratio:
The implementation study comprises a cohort study (parent study) conducted among YW and three sub-studies:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(Parent study: YW cohort study):
Exclusion criteria
Currently taking PrEP (refilled a PrEP prescription within the past 28 days at enrollment).
Inclusion criteria
(Sub-study: YW household survey):
Exclusion criteria
(Sub-study: YW household survey): N/A
Inclusion criteria
(Study pharmacies):
Exclusion criteria
(Study pharmacies): N/A
Inclusion criteria
(Sub-study: Pharmacy staff):
Exclusion criteria
(Sub-study: Pharmacy staff): N/A
Inclusion criteria
(Sub-study: Stakeholders):
Exclusion criteria
(Sub-study: Stakeholders): N/A
Provision of PrEP services to AGYW in pharmacies.
Provision of free HIV self-test kits to AGYW in pharmacies.
Time frame: 9 months
YW received a PrEP refill for all months during which an YW reports being at risk for HIV and PrEP eligible over the 9-month study period (among PrEP initiates only)
Time frame: 9 months
YW picked up all scheduled PrEP refills without a delay of >28 days over the 9- month study period (among PrEP initiates only)
Time frame: 9 months
Heard of pharmacy-based PrEP services (including screening, referrals, refills, or initiation)
Time frame: 9 months, 15 months
YW agrees that PrEP implementation model is acceptable (e.g., satisfactory, high-quality, youth-friendly, discreet, affordable); Pharmacy staff agree that PrEP implementation model is acceptable and/or consistent with AGYW needs
Time frame: 9 months, 15 months
Pharmacy provision of PrEP services (screen, provide referral, refill, or initiate AGYW on PrEP) at least once per month
Time frame: 9 months, 15 months
Agrees that PrEP implementation model at pharmacies is more accessible than seeking PrEP services at health facilities; Agrees that there is sufficient capacity (e.g., space, time, privacy, will) to deliver a particular PrEP implementation model
Time frame: 9 months, 15 months
Pharmacy is implementing the PrEP model as assigned.
Contact information is provided by the study sponsor or research team.
Lila A Sheira, PhD MPH
CONTACT
Mackfallen G Anasel, PhD
CONTACT
Mzumbe University - Centre of Excellence in Health Monitoring and Evaluation
Other
MWOTAJI: Making Women's Options for HIV Prevention In Tanzania Accessible, and Joining in Implementation Science Capacity Building
Acronym: MWOTAJI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07438041
HIV, PrEP Adherence
San Francisco, California, United States
View Trial DetailsNCT06931106
Behavior, Behavior Changes
View Trial DetailsNCT06930508
HIV, PreP
Providence, Rhode Island, United States
View Trial DetailsNCT05599581
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kisumu, Kenya
View Trial Details